Vaccines

Front Cover
Elsevier Health Sciences, 2008 - Medical - 1725 pages
Completely revised and updated, this respected reference offers comprehensive and current coverage of every aspect of vaccination-from development to use in reducing disease. It provides authoritative information on vaccine production, available preparations, efficacy, and safety.recommendations for vaccine use, with rationales.data on the impact of vaccination programs on morbidity and mortality.and more. And now, as an Expert Consult title, it includes a companion web site offering this unparalleled guidance where and when you need it most!
  • Provides a complete understanding of each disease, including clinical characteristics, microbiology, pathogenesis, diagnosis, and treatment, as well an epidemiology and public health issues.
  • Offers comprehensive coverage of both existing vaccines and vaccines currently in the research and development stage.
  • Examines vaccine stability, immunogenicity, efficacy, duration of immunity, adverse events, indications, contraindications, precautions, administration with other vaccines, and disease control strategies.
  • Analyses the cost-benefit and cost-effectiveness of vaccines.
  • Discusses the proper use of immune globulins and antitoxins.
  • Illustrates concepts and objective data with approximately 600 tables and figures.
  • Includes access to a companion web site offering the complete contents of the book - fully searchable - for rapid consultation from anyplace with an Internet connection.
 

Contents

General aspects of vaccination
17
The vaccine industry
37
1
45
37
53
Immunologic adjuvants
62
Vaccine additives and manufacturing residuals in United States licensed
77
General immunization practices
99
Atkinson Andrew L Kroger Larry K Pickering
111
Yellow fever vaccine
959
Zoster vaccine
1057
Combination vaccines
1069
Biodefense and special pathogen vaccines
1123
Vaccines in development and new vaccine strategies
1135
Cytomegalovirus vaccines
1147
Diarrheal disease vaccines
1163
EpsteinBarr virus vaccines
1181

Anthrax vaccines
125
Cholera vaccines
131
Diphtheria toxoid
141
Aruna Chandran James P Watt Mathuram Santosham
157
Hepatitis A vaccines
177
Hepatitis B vaccines
205
Human papillomavirus vaccines
251
Inactivated influenza vaccines
269
Robert B Belshe Robert Walker Jeffrey J Stoddard George Kemble Husein F Maassab
291
177
307
Japanese encephalitis virus vaccines
311
205
323
291
330
Mumps vaccines
435
Pertussis vaccines
467
Plague vaccines
519
Pneumococcal polysaccharide vaccines
569
Poliovirus vaccine inactivated
605
Poliovirus vaccinelive
631
Rabies vaccines
687
Rubella vaccine
735
Smallpox and vaccinia
773
Tetanus toxoid
805
Tickborne encephalitis virus vaccines
841
Tuberculosis vaccines
857
Typhoid fever vaccines
887
Varicella vaccine
915
Hepatitis E virus vaccines
1201
Adenovirus vaccines 1103
1225
Lyme disease vaccines
1253
Malaria vaccines
1267
Respiratory syncytial virus and parainfluenza virus vaccines
1283
Severe acute respiratory syndrome SARS vaccines
1301
Streptococcus group A vaccines
1317
Technologies for making new vaccines
1335
Alternative vaccine delivery methods
1357
The development of genebased vectors for immunization
1393
Vaccination in the immunocompromised host
1403
Vaccination of human immunodeficiency virusinfected persons
1417
Vaccines for international travel
1431
Vaccines for health care workers
1453
Immunization in the United States
1479
Immunization in Europe
1511
Immunization in the AsiaPacific region
1525
Immunization in developing countries
1541
Community immunity
1573
Economic analyses of vaccine policies
1593
Regulation and testing of vaccines
1611
Vaccine safety
1629
Legal issues
1651
Ethics
1677
Appendix 1
1685
Index
1691
Copyright

Common terms and phrases

Bibliographic information